FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
Stéphane Hunot(Centre National de la Recherche Scientifique), Étienne C. Hirsch(Sorbonne Université)
Cited by 409
Related Papers
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,<i>In Vitro,</i>Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells
|Journal of Neuroscience|1999|359
Gait Disorders in Parkinsonian Monkeys with Pedunculopontine Nucleus Lesions: A Tale of Two Systems
|Journal of Neuroscience|2013|86